Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—Specialty & Generic Average - - - - - - 535,822.37 29,942.59 1,431.11 106,807.11 -688.03 0.15 20.4337 36.12 30.9854 -126.4111 0.19 4.16 192.2432 - -
Maximum - - - - - - 9,731,303.00 444,593.00 12,710.00 1,955,691.00 6,978.00 1.00 268.1192 319.88 93.1700 69.5400 7.56 145.73 1,374.4000 - -
Minimum - - - - - - 0.00 0.00 -101.00 -13,707.00 -17,092.00 0.00 -183.3601 -0.63 -392.5400 -4,237.3100 -30.79 -89.90 0.0000 - -
Alkermes plc ALKS 28.35 0.52 1.87% 1,100 vs. 1,784 4,668.00 350.00 36.00 12.00 -1,306.00 0.2200 31.0625 0.00 82.56 10.51 2.94 1.73 231.41 164.00
Neurocrine Biosciences, Inc. NBIX 120.46 0.61 0.51% 787 vs. 925 12,163.00 515.00 43.00 119.00 -113.00 0.4300 81.2772 0.00 97.52 8.42 1.82 1.25 233.03 100.00
Evotec SE EVOTF 7.10 0.00 0.00% 0 vs. 0 1,258.00 208.00 -20.00 -86.00 -496.00 -0.1200 -20.3101 0.00 16.65 -9.90 -1.87 -0.94 163.37 177.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for EVOTF and its peers to uncover potential buy and sell opportunities.